A parliamentary panel urged India to create a single, independent Ayush drug regulator. It called for unified standards, better ADR reporting, and a digital CTMS to ensure safety and global trust.

Background The growing population of patients with adult congenital heart disease (ACHD) present complex lifelong care needs ...

Coherus Oncology, Inc. is rated a Buy driven by a promising clinical pipeline and undervaluation. Learn more about CHRS stock ...

Immuneering Corporation (Nasdaq: IMRX), a late-stage clinical oncology company focused on keeping cancer patients alive and helping them thrive, today announced that it will host a conference call and ...

Artificial intelligence (AI) is poised to transform nuclear medicine along multiple, interconnected directions. On the translational side, AI can accelerate ...